Braden Barbara, Koutsoumpas Andreas, Silva Michael A, Soonawalla Zahir, Dietrich Christoph F
Translational Gastroenterology Unit, Oxford University Hospitals, Oxford OX3 9DU, United Kingdom.
Hepatobiliary Surgery, Oxford University Hospitals, Oxford OX3 9DU, United Kingdom.
World J Gastrointest Endosc. 2018 May 16;10(5):93-98. doi: 10.4253/wjge.v10.i5.93.
To investigate whether endoscopic ultrasound (EUS)-guided insertion of fully covered self-expandable metal stents in walled-off pancreatic necrosis (WOPN) is feasible without fluoroscopy.
Patients with symptomatic pancreatic WOPN undergoing EUS-guided transmural drainage using self-expandable and fully covered self expanding metal stents (FCSEMS) were included. The EUS visibility of each step involved in the transmural stent insertion was assessed by the operators as "visible" or "not visible": (1) Access to the cyst by needle or cystotome; (2) insertion of a guide wire; (3) introducing of the diathermy and delivery system; (4) opening of the distal flange; and (5) slow withdrawal of the delivery system until contact of distal flange to cavity wall. Technical success was defined as correct positioning of the FCSEMS without the need of fluoroscopy.
In total, 27 consecutive patients with symptomatic WOPN referred for EUS-guided drainage were included. In 2 patients large traversing arteries within the cavity were detected by color Doppler, therefore the insertion of FCSEMS was not attempted. In all other patients (92.6%) EUS-guided transgastric stent insertion was technically successful without fluoroscopy. All steps of the procedure could be clearly visualized by EUS. Nine patients required endoscopic necrosectomy through the FCSEMS. Adverse events were two readmissions with fever and one self-limiting bleeding; there was no procedure-related mortality.
The good endosonographic visibility of the FCSEMS delivery system throughout the procedure allows safe EUS-guided insertion without fluoroscopy making it available as bedside intervention for critically ill patients.
探讨在无荧光透视的情况下,内镜超声(EUS)引导下将全覆膜自膨式金属支架置入壁内型胰腺坏死(WOPN)是否可行。
纳入有症状的WOPN患者,这些患者接受了EUS引导下使用自膨式全覆膜自膨式金属支架(FCSEMS)进行的经壁引流。操作医生将经壁支架置入过程中每个步骤的EUS可视性评估为“可见”或“不可见”:(1)用穿刺针或切开刀进入囊肿;(2)插入导丝;(3)引入透热和输送系统;(4)打开远端翼缘;(5)缓慢撤回输送系统,直到远端翼缘接触腔壁。技术成功定义为FCSEMS无需荧光透视即可正确定位。
总共纳入了27例因有症状的WOPN而接受EUS引导下引流的连续患者。2例患者通过彩色多普勒检测到腔内有大的穿行动脉,因此未尝试插入FCSEMS。在所有其他患者(92.6%)中,EUS引导下经胃支架置入在无荧光透视的情况下技术成功。该操作的所有步骤均可通过EUS清晰可视化。9例患者需要通过FCSEMS进行内镜坏死组织清除术。不良事件包括2例因发热再次入院和1例自限性出血;无手术相关死亡。
在整个操作过程中,FCSEMS输送系统具有良好的内镜超声可视性,无需荧光透视即可安全地进行EUS引导下的置入,使其可作为重症患者的床边干预措施。